v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 34 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Dec. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:                
Net loss $ (253,794) $ 91,202 $ (38,403) $ (17,864) $ (162,592) $ (56,267)    
Adjustments to reconcile net loss to net cash used in operating activities                
Depreciation         0 195    
Non-cash interest expense         513 768    
Non-cash gain on foreign currency remeasurement         (1,396) (1,885)    
Non-cash share-based compensation expense         6,923 7,531    
Non-cash lease expenses         1,032 1,169    
Transaction costs allocated to warrants         643 5,778    
Fair value change of warrant liabilities 205,577   2,540   74,661 (16,920)    
Changes in operating assets and liabilities                
Prepaid expenses and other current assets         (981) (14,369)    
Deferred and prepaid tax assets         (804) (515)    
Other assets         (9,030) (1,445)    
Operating lease liabilities         (1,047) (1,174)    
Accounts payable         (2,820) (2,337)    
Accrued expenses and other liabilities         6,656 (4,875)    
Net cash used in operating activities         (88,242) (84,346)    
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from conversion of ADS warrants into pre-funded warrants         115,333 0    
Payments of tax withholdings on stock award         (239) 0    
Proceeds from issuance of shares under the employee share purchase plan         160 157    
Net proceeds from issuance of long term debt         18,582 0    
Proceeds from exercise of options         1,151 11    
Proceeds from issuance of pre-funded warrants associated with the 2025 Offering, net of issuance costs         1 0    
Net cash provided by financing activities         370,013 140,525    
Effect of exchange rate changes on cash, cash equivalents and restricted cash         1,962 611    
Net increase in cash, cash equivalents and restricted cash         283,733 56,790    
Cash, cash equivalents and restricted cash, beginning of the period   $ 149,987   $ 165,470 149,987 165,470    
Cash, cash equivalents and restricted cash, end of the period 433,720   222,260   433,720 222,260 $ 433,720  
Supplemental Cash Flow Elements [Abstract]                
Cash and cash equivalents 433,295   221,881   433,295 221,881 433,295 $ 149,608
Restricted cash 425   379   425 379 425 379
Total cash, cash equivalents and restricted cash $ 433,720   $ 222,260   433,720 222,260 433,720 $ 149,987
2026 Offering                
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from Issuance of Common Stock         140,643 140,357    
At-The-Market Offering                
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from Issuance of Common Stock         1,397 0    
ADS Warrants                
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from the exercise of warrants         87,871 0    
PIPE Warrants                
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from the exercise of warrants         $ 5,114 $ 42,400